查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842339

全球甲狀腺癌診斷市場：市場規模、佔有率、趨勢分析（按癌症類型、技術、最終用途和地區分類）、細分市場預測（2025-2033 年）

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report By Cancer Type (Papillary Carcinoma, Follicular Carcinoma), By Technique (Imaging, Biopsy), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

甲狀腺癌診斷：市場概覽

全球甲狀腺癌診斷市場預計在 2024 年達到 30.7 億美元，預計到 2033 年將達到 50.3 億美元，2025 年至 2033 年的複合年成長率為 5.86%。

這一成長歸因於甲狀腺癌發病率的上升、人們對早期篩檢計畫的認知不斷提高，以及影像方式和分子檢測等診斷工具的重大技術進步。

此外，醫療保健支出不斷成長、有利的報銷政策以及向個人化醫療的轉變也是推動市場擴張的部分因素。此外，人口老化、醫療基礎設施的改善以及持續的研發投入也進一步推動了市場擴張，從而能夠早期、準確地檢測和治療甲狀腺癌。

甲狀腺癌診斷涵蓋一系列廣泛的檢測和程序，包括影像學檢查、切片檢查、血液檢查和分子譜分析，用於檢測和表徵甲狀腺癌，並指南臨床決策和個人化治療。由於甲狀腺癌患者數量的不斷增加，全球甲狀腺癌診斷市場正在迅速擴張。患者數量的成長推動了對早期檢測和有效篩檢工具的需求，醫療機構優先考慮主動識別以改善預後。根據美國癌症協會預測，2025年美國預計將新增約44,020例甲狀腺癌病例，其中約31,350例為女性，約12,670例為男性。甲狀腺癌在女性中更為常見，通常在比許多其他癌症更年輕時被診斷出來。

技術進步是推動該市場發展的主要動力。例如，2024年5月，GE醫療推出了Revolution RT，這是一款先進的放射治療電腦斷層掃描（CT）解決方案。此創新系統旨在提高影像精度、簡化模擬工作流程，並支援更個人化和無縫的腫瘤治療。 Revolution RT融合了人工智慧主導技術和現代化的軟體平台，使臨床醫生能夠實現精準的腫瘤靶向和更高效的治療方案。

此外，遠端醫療和數位健康平台的普及進一步擴大了甲狀腺癌診斷的覆蓋範圍，尤其惠及偏遠和醫療資源匱乏地區的居民。透過遠距會診，患者可以獲得早期篩檢建議和後續治療，確保及時干預，不受地理限制。

此外，遺傳風險因素基因檢測的日益普及也為市場創造了新的機會。先進的基因組檢測可以識別與甲狀腺腫瘤相關的突變，有助於更精準的診斷和個人化的治療策略。甲狀腺癌發病率的上升、Revolution RT等最尖端科技的出現、個人化醫療的興起、數位醫療的普及以及基因檢測的擴展——這些因素共同推動了甲狀腺癌診斷行業的強勁成長，從而實現更早期的檢測和更優質的患者照護。

目錄

第1章 分析方法和範圍

第2章執行摘要

3. 全球甲狀腺癌診斷市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 甲狀腺癌診斷市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析

第4章 全球甲狀腺癌診斷市場：按癌症類型分類的商業分析

  • 癌症類型儀錶板
  • 甲狀腺癌診斷市場：按癌症類型分類的波動分析
  • 全球甲狀腺癌診斷市場規模及趨勢分析（按癌症類型分類）（2021-2033 年）
  • 乳頭狀癌
  • 濾泡癌
  • 其他

5. 全球甲狀腺癌診斷市場：按技術分類的業務分析

  • 技術專用儀錶板
  • 甲狀腺癌診斷市場：依技術分類的差異分析
  • 全球甲狀腺癌診斷市場規模及技術趨勢分析（2021-2033）
  • 血液檢查
  • 影像診斷
  • 切片檢查
  • 其他

6. 全球甲狀腺癌診斷市場：按最終用途分類的業務分析

  • 按最終用戶分類的儀表板
  • 甲狀腺癌診斷市場：依最終用途分類的差異分析
  • 全球甲狀腺癌診斷市場規模及趨勢分析（按最終用途分類）（2021-2033 年）
  • 醫院檢查室
  • 癌症診斷中心
  • 研究所
  • 其他

第7章 全球甲狀腺癌診斷市場：區域估算與趨勢分析

  • 市場概覽：按地區
  • 按地區分類的市場佔有率分析（2024 年和 2033 年）
  • 甲狀腺癌診斷市場：關鍵點（按地區分類）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要企業熱力圖分析（2024 年）
  • 公司簡介
    • Abbott
    • F.Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific, Inc.
    • Siemens Healthcare GmbH
    • Bio-Rad Laboratories, Inc.
    • GE HealthCare
    • Hologic, Inc.
    • Koninklijke Philips NV
    • Toshiba Corporation
    • Agilent Technologies, Inc.
    • Illumina, Inc.
Product Code: GVR-4-68038-615-8

Thyroid Cancer Diagnostics Market Summary

The global thyroid cancer diagnostics market size was estimated at USD 3.07 billion in 2024 and is projected to reach USD 5.03 billion by 2033, growing at a CAGR of 5.86% from 2025 to 2033. This growth is attributed to the growing incidence of thyroid cancer, growing awareness of early screening programs, and significant technological advancements in diagnostic tools such as imaging modalities and molecular testing.

In addition, increased healthcare spending, favorable reimbursement policies, and a shift toward personalized medicine. Furthermore, the growing aging population, improved healthcare infrastructure, and ongoing research and development efforts further support market expansion, enabling earlier and more accurate detection and management of thyroid cancer.

Thyroid cancer diagnostics encompass a broad range of tests and procedures, including imaging, biopsies, blood tests, and molecular profiling used to detect and characterize thyroid cancer, guiding clinical decisions and personalized treatment. The global market for these diagnostics is expanding rapidly, largely due to the increasing number of thyroid cancer patients. This rise in cases has heightened the demand for early detection and effective screening tools, as healthcare providers prioritize proactive identification to improve outcomes. According to the American Cancer Society, about 44,020 new cases of thyroid cancer are expected to be diagnosed in the U.S. in 2025. Approximately 31,350 cases occur in women and 12,670 in men. Thyroid cancer is notably more common in women and is often diagnosed at a younger age compared to many other cancers.

A significant driver of this market is technological advancement. For instance, in May 2024, GE Healthcare introduced Revolution RT, an advanced radiation therapy computed tomography (CT) solution. This innovative system is designed to enhance imaging accuracy and streamline simulation workflows, supporting a more personalized and seamless oncology care experience. Revolution RT incorporates AI-driven technologies and updated software platforms, enabling clinicians to achieve precise tumor targeting and more efficient care pathways.

In addition, the adoption of telemedicine and digital health platforms has further expanded access to thyroid cancer diagnostics, especially for individuals in remote or underserved areas. Through virtual consultations, patients can receive early screening recommendations and follow-up care, ensuring timely intervention regardless of geographic barriers.

Moreover, the growing prevalence of genetic testing for hereditary risk factors is creating new opportunities in the market. Advanced genomic panels can identify mutations linked to thyroid tumors, aiding in more accurate diagnosis and personalized treatment strategies. Collectively, these factors, including the rising incidence of thyroid cancer, cutting-edge technology like Revolution RT, the shift toward personalized medicine, digital health accessibility, and expanded genetic testing, are driving robust growth in the thyroid cancer diagnostics industry, leading to earlier detection and improved patient care.

Global Thyroid Cancer Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global thyroid cancer diagnostics market report based on cancer type, technique, end use, and region.

  • Cancer Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Papillary carcinoma
  • Follicular carcinoma
  • Others
  • Technique Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood Test
  • Imaging
  • Biopsy
  • Others
  • End Use Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Laboratories
  • Cancer Diagnostic Centers
  • Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Cancer Type
    • 1.2.2. Technique
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Cancer Type Outlook
    • 2.2.2. Technique Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Thyroid Cancer Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Thyroid Cancer Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Thyroid Cancer Diagnostics Market: Cancer Type Business Analysis

  • 4.1. Cancer Type Segment Dashboard
  • 4.2. Thyroid Cancer Diagnostics Market: Cancer Type Movement Analysis
  • 4.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Cancer Type, 2021 to 2033 (USD Million)
  • 4.4. Papillary carcinoma
    • 4.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 4.5. Follicular carcinoma
    • 4.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 5. Global Thyroid Cancer Diagnostics Market: Technique Business Analysis

  • 5.1. Technique Segment Dashboard
  • 5.2. Thyroid Cancer Diagnostics Market: Technique Movement Analysis
  • 5.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Technique, 2021 to 2033 (USD Million)
  • 5.4. Blood Test
    • 5.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.5. Imaging
    • 5.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.6. Biopsy
    • 5.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. Global Thyroid Cancer Diagnostics Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Thyroid Cancer Diagnostics Market: End Use Movement Analysis
  • 6.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospital Laboratories
    • 6.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.5. Cancer Diagnostic Centers
    • 6.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.6. Research Institutes
    • 6.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 7. Global Thyroid Cancer Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2033
  • 7.3. Global Thyroid Cancer Diagnostics Market by Regional: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. South Korea Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Argentina Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. F.Hoffmann-La Roche Ltd.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Thermo Fisher Scientific, Inc.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Siemens Healthcare GmbH
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc.
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. GE HealthCare
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Hologic, Inc.
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Koninklijke Philips N.V.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Toshiba Corporation
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Agilent Technologies, Inc.
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Illumina, Inc.
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 3 Global Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 4 Global Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 5 Global Thyroid Cancer Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 6 North America Thyroid Cancer Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 7 North America Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 8 North America Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 9 North America Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 U.S Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 11 U.S Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 12 U.S Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 14 Canada Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 15 Canada Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 18 Mexico Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Thyroid Cancer Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 21 Europe Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 22 Europe Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Germany Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 24 Germany Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 25 Germany Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 26 UK Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 27 UK Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 28 UK Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 France Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 30 France Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 31 France Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 33 Italy Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 34 Italy Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 36 Spain Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 37 Spain Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 39 Denmark Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 40 Denmark Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 42 Sweden Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 43 Sweden Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 45 Norway Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 46 Norway Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Thyroid Cancer Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 China Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 52 China Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 53 China Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Japan Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 55 Japan Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 56 Japan Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 57 India Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 58 India Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 59 India Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 60 South Korea Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 61 South Korea Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 62 South Korea Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 63 Australia Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 64 Australia Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 65 Australia Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 67 Thailand Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 68 Thailand Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Thyroid Cancer Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 71 Latin America Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 72 Latin America Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 74 Brazil Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 75 Argentina Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 76 Argentina Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 77 Argentina Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 78 MEA Thyroid Cancer Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 79 MEA Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 80 MEA Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 81 MEA Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 82 South Africa Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 83 South Africa Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 84 South Africa Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 88 UAE Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 89 UAE Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 90 UAE Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Kuwait Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Thyroid Cancer Diagnostics Market: Market Outlook
  • Fig. 10 Thyroid Cancer Diagnostics Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Thyroid Cancer Diagnostics Market Driver Impact
  • Fig. 16 Thyroid Cancer Diagnostics Market Restraint Impact
  • Fig. 17 Thyroid Cancer Diagnostics Market Strategic Initiatives Analysis
  • Fig. 18 Thyroid Cancer Diagnostics Market: Cancer Type Movement Analysis
  • Fig. 19 Thyroid Cancer Diagnostics Market: Cancer Type Outlook and Key Takeaways
  • Fig. 20 Papillary Carcinoma Market Estimates and Forecast, 2021 - 2033
  • Fig. 21 Follicular Carcinoma Market Estimates and Forecast, 2021 - 2033
  • Fig. 22 Others Market Estimates and Forecast, 2021 - 2033
  • Fig. 23 Thyroid Cancer Diagnostics Market: Technique Movement Analysis
  • Fig. 24 Thyroid Cancer Diagnostics Market: Technique Outlook and Key Takeaways
  • Fig. 25 Blood Test Market Estimates and Forecast, 2021 - 2033
  • Fig. 26 Imaging Market Estimates and Forecast, 2021 - 2033
  • Fig. 27 Biopsy Market Estimates and Forecast, 2021 - 2033
  • Fig. 28 Others Market Estimates and Forecast, 2021 - 2033
  • Fig. 29 Thyroid Cancer Diagnostics Market: End Use Movement Analysis
  • Fig. 30 Thyroid Cancer Diagnostics Market: End Use Outlook and Key Takeaways
  • Fig. 31 Hospital Laboratories Market Estimates and Forecasts, 2021 - 2033
  • Fig. 32 Cancer Diagnostic Centers Market Estimates and Forecasts, 2021 - 2033
  • Fig. 33 Research Institutes Market Estimates and Forecasts, 2021 - 2033
  • Fig. 34 Others Market Estimates and Forecasts, 2021 - 2033
  • Fig. 35 Global Thyroid Cancer Diagnostics Market: Regional Movement Analysis
  • Fig. 36 Global Thyroid Cancer Diagnostics Market: Regional Outlook and Key Takeaways
  • Fig. 37 North America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 38 U.S Market Estimates and Forecasts, 2021 - 2033
  • Fig. 39 Canada Market Estimates and Forecasts, 2021 - 2033
  • Fig. 40 Mexico Market Estimates and Forecasts, 2021 - 2033
  • Fig. 41 Europe Market Estimates and Forecasts, 2021 - 2033
  • Fig. 42 UK Market Estimates and Forecasts, 2021 - 2033
  • Fig. 43 Germany Market Estimates and Forecasts, 2021 - 2033
  • Fig. 44 France Market Estimates and Forecasts, 2021 - 2033
  • Fig. 45 Italy Market Estimates and Forecasts, 2021 - 2033
  • Fig. 46 Spain Market Estimates and Forecasts, 2021 - 2033
  • Fig. 47 Denmark Market Estimates and Forecasts, 2021 - 2033
  • Fig. 48 Sweden Market Estimates and Forecasts, 2021 - 2033
  • Fig. 49 Norway Market Estimates and Forecasts, 2021 - 2033
  • Fig. 50 Asia Pacific Market Estimates and Forecasts, 2021 - 2033
  • Fig. 51 China Market Estimates and Forecasts, 2021 - 2033
  • Fig. 52 Japan Market Estimates and Forecasts, 2021 - 2033
  • Fig. 53 India Market Estimates and Forecasts, 2021 - 2033
  • Fig. 54 Thailand Market Estimates and Forecasts, 2021 - 2033
  • Fig. 55 South Korea Market Estimates and Forecasts, 2021 - 2033
  • Fig. 56 Australia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 57 Latin America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 58 Brazil Market Estimates and Forecasts, 2021 - 2033
  • Fig. 59 Argentina Market Estimates and Forecasts, 2021 - 2033
  • Fig. 60 Middle East and Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 61 South Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 62 Saudi Arabia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 63 UAE Market Estimates and Forecasts, 2021 - 2033
  • Fig. 64 Kuwait Market Estimates and Forecasts, 2021 - 2033